Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Gentian Diagnostics - Grant of options

GENTSelskabsmeddelelse06.11.2026, 10.27
Læs udgivelse
Moss, 6 November 2026

Reference is made to the annual general meeting 6 May 2025 where guidelines for
remuneration of executive personnel were approved. In accordance with these
guidelines the board of Gentian Diagnostics ASA has allocated a total of 485,000
options to key employees under the existing option program.

The following number of options have been allocated to primary insiders of
Gentian Diagnostics ASA:

Matti Heinonen, Chief Executive Officer: 100,000 options with a strike price of
NOK 60.00 and 100,000 options with a strike price of NOK 44.00. Following the
grant, Mr. Heinonen holds 15,569 shares and 300,000 options in the Company.

Njaal Kind, Group Chief Financial Officer: 50,000 options with a strike price of
NOK 60.00 and 50,000 options with a strike price of NOK 44.00. Following the
allocation Mr. Kind holds 32,194 shares and 240,670 options in the Company.

Aleksandra Havelka, Chief Scientific Officer: 20,000 options with a strike price
of NOK 44.00. Following the allocation Ms. Havelka hold 2,920 shares and 100,000
options in the Company.

Hanne Kristiansen, Vice President Commercial: 20,000 options with a strike price
of NOK 60.00 and 20,000 options with a strike price of NOK 44.00. Following the
allocation Ms. Kristiansen holds 1,023 shares and 40,000 options in the Company.

The right to exercise the options is vested over a period of 2 years, with 50%
of the options vesting by the end of each year as follows: (i) 50% of the
options granted, no earlier than 3 years after the allocation date, (ii) 50% of
the options granted, no earlier than 4 years after the allocation date at an The
options may also be exercised at expiry after 5 years.

Attached are the notifications of the transactions pursuant to the market abuse
regulation article 19. This information is subject to the disclosure
requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

For further information, please contact:
Njaal Kind CFO, Gentian Diagnostics ASA
E-mail: njaal.kind@gentian.no
Phone: +47 919 06 525
gnostics ASA \
E-mail: njaal.kind@gentian.no \
Phone: +47 919 06 525\